- Home
- AURE vs APM Comparison
AURE vs APM Comparison
Compare AURE & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AURE
- APM
- Stock Information
- Founded
- AURE 2018
- APM 2010
- Country
- AURE Hong Kong
- APM United Kingdom
- Employees
- AURE N/A
- APM N/A
- Industry
- AURE Finance: Consumer Services
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- AURE Finance
- APM Health Care
- Exchange
- AURE Nasdaq
- APM Nasdaq
- Market Cap
- AURE 19.4M
- APM 18.9M
- IPO Year
- AURE N/A
- APM 2018
- Fundamental
- Price
- AURE $0.43
- APM $1.50
- Analyst Decision
- AURE
- APM
- Analyst Count
- AURE 0
- APM 0
- Target Price
- AURE N/A
- APM N/A
- AVG Volume (30 Days)
- AURE 177.7K
- APM 103.1K
- Earning Date
- AURE 02-13-2026
- APM 12-19-2025
- Dividend Yield
- AURE N/A
- APM N/A
- EPS Growth
- AURE N/A
- APM N/A
- EPS
- AURE N/A
- APM N/A
- Revenue
- AURE $142,570.00
- APM N/A
- Revenue This Year
- AURE N/A
- APM N/A
- Revenue Next Year
- AURE N/A
- APM N/A
- P/E Ratio
- AURE N/A
- APM N/A
- Revenue Growth
- AURE N/A
- APM N/A
- 52 Week Low
- AURE $0.31
- APM $0.46
- 52 Week High
- AURE $2.70
- APM $7.49
- Technical
- Relative Strength Index (RSI)
- AURE N/A
- APM 51.51
- Support Level
- AURE N/A
- APM $1.33
- Resistance Level
- AURE N/A
- APM $1.48
- Average True Range (ATR)
- AURE 0.00
- APM 0.07
- MACD
- AURE 0.00
- APM 0.02
- Stochastic Oscillator
- AURE 0.00
- APM 60.53
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.